| Hair cortisol analysis: An update on methodological considerations and clinical applications MJE Greff, JM Levine, AM Abuzgaia, AA Elzagallaai, MJ Rieder, ... Clinical biochemistry 63, 1-9, 2019 | 242 | 2019 |
| Potentiation of thromboxane A2-induced platelet secretion by Gi signaling through the phosphoinositide-3 kinase pathway C Dangelmaier, J Jin, BJ Smith, SP Kunapuli Thrombosis and haemostasis 85 (02), 341-348, 2001 | 132 | 2001 |
| Two pathways control chromaffin cell corticalF-actin dynamics during exocytosis JM Trifaró, SD Rosé, T Lejen, A Elzagallaai Biochimie 82 (4), 339-352, 2000 | 116 | 2000 |
| Platelet secretion induced by phorbol esters stimulation is mediated through phosphorylation of MARCKS: a MARCKS-derived peptide blocks MARCKS phosphorylation and serotonin … A Elzagallaai, SD Rosé, JM Trifaró Blood, The Journal of the American Society of Hematology 95 (3), 894-902, 2000 | 112 | 2000 |
| Adverse drug reactions in children: the double‐edged sword of therapeutics AA Elzagallaai, MJE Greff, MJ Rieder Clinical Pharmacology & Therapeutics 101 (6), 725-735, 2017 | 107 | 2017 |
| Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review AA Elzagallaai, SR Knowles, MJ Rieder, JR Bend, NH Shear, G Koren Drug safety 32, 391-408, 2009 | 99 | 2009 |
| The effect of corrected inflammation, oxidative stress and endothelial dysfunction on fmd levels in patients with selected chronic diseases: a quasi-experimental study MI Yilmaz, M Romano, MK Basarali, A Elzagallaai, M Karaman, Z Demir, ... Scientific reports 10 (1), 9018, 2020 | 53 | 2020 |
| In Vitro Testing for the Diagnosis of Anticonvulsant Hypersensitivity Syndrome: A Systematic Review AA Elzagallaai, SR Knowles, MJ Rieder, JR Bend, NH Shear, G Koren Molecular diagnosis & therapy 13, 313-330, 2009 | 49 | 2009 |
| In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology AA Elzagallaai, MJ Rieder British journal of clinical pharmacology 80 (4), 889-900, 2015 | 36 | 2015 |
| Localization by segmental deletion analysis and functional characterization of a third actin-binding site in domain 5 of scinderin MG Marcu, L Zhang, A Elzagallaai, JM Trifaró Journal of Biological Chemistry 273 (6), 3661-3668, 1998 | 31 | 1998 |
| War exposure, post-traumatic stress symptoms and hair cortisol concentrations in Syrian refugee children D Smeeth, FS McEwen, CM Popham, EG Karam, J Fayyad, D Saab, ... Molecular psychiatry 28 (2), 647-656, 2023 | 30 | 2023 |
| Role of oxidative stress in hypersensitivity reactions to sulfonamides AA Elzagallaai, EA Sultan, JR Bend, AM Abuzgaia, E Loubani, MJ Rieder The Journal of Clinical Pharmacology 60 (3), 409-421, 2020 | 30 | 2020 |
| Predictive value of the lymphocyte toxicity assay in the diagnosis of drug hypersensitivity syndrome AA Elzagallaai, Z Jahedmotlagh, BR Del Pozzo-Magana, SR Knowles, ... Molecular Diagnosis & Therapy 14, 317-322, 2010 | 29 | 2010 |
| Myristoylated alanine‐rich C kinase substrate phosphorylation is involved in thrombin‐induced serotonin release from platelets A Elzagallaai, SD Rose, NC Brandan, JM Trifaró British journal of haematology 112 (3), 593-602, 2001 | 25 | 2001 |
| An antisense oligodeoxynucleotide targeted to chromaffin cell scinderin gene decreased scinderin levels and inhibited depolarization‐induced cortical F‐actin disassembly and … T Lejen, K Skolnik, SD Rosé, MG Marcu, A Elzagallaai, JM Trifaró Journal of neurochemistry 76 (3), 768-777, 2001 | 19 | 2001 |
| The in vitro platelet toxicity assay (iPTA): a novel approach for assessment of drug hypersensitivity syndrome AA Elzagallaai, MJ Rieder, G Koren The Journal of Clinical Pharmacology 51 (3), 428-435, 2011 | 18 | 2011 |
| Severe bullous hypersensitivity reactions after exposure to carbamazepine in a Han-Chinese child with a positive HLA-B* 1502 and negative in vitro toxicity assays: evidence for … AA Elzagallaai, F Garcia-Bournissen, Y Finkelstein, JR Bend, MJ Rieder, ... Journal of Population Therapeutics and Clinical Pharmacology= Journal de la …, 2011 | 17 | 2011 |
| Pharmacogenomics in pediatric oncology: mitigating adverse drug reactions while preserving efficacy AA Elzagallaai, BC Carleton, MJ Rieder Annual review of pharmacology and toxicology 61 (1), 679-699, 2021 | 16 | 2021 |
| The predictive value of the in vitro platelet toxicity assay (iPTA) for the diagnosis of hypersensitivity reactions to sulfonamides AA Elzagallaai, G Koren, MJ Rieder The Journal of Clinical Pharmacology 53 (6), 626-632, 2013 | 16 | 2013 |
| In Vitro Testing for Hypersensitivity‐Mediated Adverse Drug Reactions: Challenges and Future Directions AA Elzagallaai, G Koren, JR Bend, MJ Rieder Clinical Pharmacology & Therapeutics 90 (3), 455-460, 2011 | 15 | 2011 |
